Key facts
- Jinkai Biotechnology’s last known valuation is $9.4M (Nov 2014).
- Notable investors include Sichuan Development Holding.
- Status: Acquired/Merged (Operating Subsidiary).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Jinkai Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Jinkai Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jinkai Biotechnology
Manufacturer of biological products catering to agriculture, food, environmental protection, daily chemical, and pharmaceutical industries. The company offers advanced, research-driven formulations, environmentally friendly production processes, and versatile product lines for the agricultural, food, environmental protection, daily chemical, and pharmaceutical sectors, enabling businesses to improve operational performance, reduce their ecological footprint, and meet safety standards in diverse markets.
- Sector
- Healthcare
- HQ
- Chengdu, China
- Founded
- 2008
- Employees
- 100
- Website
- cdjksw.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Jinkai Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jinkai Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jinkai Biotechnology in its N-PORT filings yet. We sweep new filings monthly.